BridgeMD
New treatment option for Amyotrophic Lateral Sclerosis (ALS)
Official title Testing Pulse Stimulation to Improve Motor Function in People With ALS: A Pilot Study
ClinicalTrials.gov ID: NCT06681610
What this study is testing
- What it's testing
- The goal of this clinical trial is to assess the efficacy of TPS of the motor cortex on biomarkers and clinical endpoints in patients with ALS. The main questions it aims to answer are: Stage 1: Is there a change in the short intracortical inhibition (SICI) of the motor cortex from baseline to week 8?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 21 to 80
You may be able to join if
- Patients with diagnosis of sporadic ALS (definite or clinically probable) as defined by the World Federation of Neurology revised El Escorial criteria
- SVC of 50% or greater of estimated measure and presence of measurable motor evoked potential
- 21 to 80 years old and male or female
You likely can't join if
- patients with fALS (based on medical history) that are unable to tolerate TMS and MRI studies or have a contraindication as described below
The study team makes the final eligibility decision.
Where it's taking place
- Barcelona, Catalonia, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 21 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Barcelona, Catalonia, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.